Events & presentations

An overview of Zealand Pharma

CORPORATE PRESENTATION

This presentation is intended for shareholders and investors.

Any information concerning pharmaceuticals (including compounds under development) contained within these materials is not intended as advertising or medical advice.

  • Download PDF
  • Crosby CHI NJ USA JW 0875 B3A6034

    Upcoming events

    Past events

    • Goldman Sachs 45th Annual Global Healthcare Conference

    • Webcast
    • Jefferies Global Healthcare Conference 2024

    • Webcast
    • TD Cowen’s 44th Annual Health Care Conference in Boston, MA

    • Webcast
    • Zealand Pharma at Goldman Sachs Healthcare C-Suite Unscripted Conference

    • Webcast
    • Zealand Pharma Interim Report Q3 2023

    • Webcast
    • Jefferies London Healthcare Conference

    • Webcast
    • Morgan Stanley 21st Annual Global Healthcare Conference

    • Webcast
    • Zealand Pharma Interim Report H1 2023

    • Webcast
    • Goldman Sachs 44th Annual Global Healthcare Conference

    • Jefferies Global Healthcare Conference

    • Webcast
    • 22nd Annual Needham Virtual Healthcare Conference

    • Webcast
    • Evercore ISI Annual HealthCONx Conference

    • Webcast
    • Jefferies London Healthcare Conference 2022

    • Webcast
    • Zealand Pharma Interim Report Q3 2022

    • Webcast
    • Conference Call to Discuss Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)

    • European Society for Paediatric Endocrinology 2022

    • Morgan Stanley 20th Annual Global Healthcare Conference

    • Zealand Pharma Interim Report H1 2022

    • Goldman Sachs Global Healthcare Conference

    • Jefferies 2022 Global Healthcare Conference

    • Webcast
    • Annual American Diabetes Association Scientific Sessions

    • More details
    • Zealand Pharma Interim Report Q1 2022

    • 21st Annual Needham Virtual Healthcare Conference

    • Webcast
    • Zealand Pharma Corporate Update Conference Call

    • Dial-in
    • H.C. Wainwright BIOCONNECT 2022 Conference

    Obesity R&D event

    Featured Event

    We hosted an event for investors to discuss the scientific rationale and clinical potential of our differentiated product candidates targeting obesity. Speakers at the event were Adam Steensberg, our CEO; and David Kendall, our CMO and Head of R&D, joined by three leading external experts.

  • Download presentation
  • Watch the webcast
  • Zealand Pharma 0524 FINAL HI